Cancer immunology

Results: 530



#Item
91Immunology / Immune system

Award ID: DP150061 Project Title: Preclinical Development of a Therapeutic Enzyme for Immune Checkpoint Inhibition in Cancer Award Mechanism:

Add to Reading List

Source URL: www.cprit.state.tx.us

Language: English - Date: 2014-11-20 01:49:50
92Biotechnology / HER2/neu / Ribbon symbolism / Immunology / Pertuzumab / Trastuzumab / Targeted therapy / Breast cancer / Bispecific monoclonal antibody / Monoclonal antibodies / Medicine / Biology

F-star Announces Initiation of a Phase 1 Clinical Trial for FS102 for the Treatment of HER2-Positive Breast and Gastric Cancer CAMBRIDGE, UK – 9 JanuaryF-star, a biopharmaceutical company focused on oncology and

Add to Reading List

Source URL: www.f-star.com

Language: English - Date: 2015-01-09 11:56:08
93Immune system / Immunotherapy / Cancer immunotherapy / Cancer vaccine / Northwest Biotherapeutics / Medicine / Immunology / Cancer treatments

Award ID: DP150029 Project Title: Personalized Cellular Immunotherapy against Novel Cancer Targets Award Mechanism: New Company Product Development Award

Add to Reading List

Source URL: www.cprit.state.tx.us

Language: English - Date: 2015-03-12 19:44:28
94Health / Immunology / Cancer treatments / Pharmaceuticals policy / Pharmaceutical industry / Pharmacy / Bristol-Myers Squibb / Immunotherapy / Melanoma / Medicine / Pharmacology / Pharmaceutical sciences

cover story Overcoming disease through specialization Cooperation within the healthcare industry Innovating new treatments and therapies PHARMA – FOR A

Add to Reading List

Source URL: www.amcham.de

Language: English - Date: 2015-04-28 05:36:44
95Immune system / Anatomy / Vaccination / Immunogenicity / Cancer vaccine / Vaccine / Epitope / Antigen / Peptide / Medicine / Immunology / Biology

Personalized Neoantigen Vaccination with Synthetic Long Peptides John P. Finnigan, Alex Rubinsteyn, Tavi Nathanson, Nicholas Akers, Nina Bhardwaj, Jeff Hammerbacher, Bojan Losic, Eric Schadt Icahn School of Medicine at M

Add to Reading List

Source URL: www.rubinsteyn.com

Language: English - Date: 2015-02-02 14:13:36
96Experimental cancer treatments / Oncolytic virus / Immunology / Medical research / Immunotherapy / Gene therapy / Reolysin / Medicine / Biology / Viruses

FINAL FOR DISTRIBUTION PSIOXUS THERAPEUTICS RAISES A £25M SERIES C INVESTMENT TO PROGRESS ONCOLYTIC VIRUS PLUS CHECKPOINT INHIBITOR COMBINATION STUDY IN METASTATIC COLORECTAL CANCER OXFORD, UK – 19 May 2015 – PsiOxu

Add to Reading List

Source URL: www.psioxus.com

Language: English - Date: 2015-05-19 03:49:40
97Institute of Medical Science / University of Tokyo / Cancer research

The 10th International Symposium of the Institute Network 第10回 研究所ネットワーク国際シンポジウム Towards the next generation research for cancer and Immunology Date: July 23(Thu) – 24(Fri), 2015

Add to Reading List

Source URL: www.igm.hokudai.ac.jp

Language: English - Date: 2015-05-14 19:51:23
98T cells / Monoclonal antibodies / Oncology / Prostate-specific membrane antigen / Lymphocyte / Prostate cancer / PC3 / Immunotherapy / Cancer immunotherapy / Medicine / Immunology / Immune system

Bispecific PSMAxCD3 Diabody Novel Immunotherapeutic Agent for Prostate Cancer Technology In the field of cancer immunotherapy, the retargeting of T-cells to tumor cells by bispecific antibodies or diabodies is an appeali

Add to Reading List

Source URL: www.campus-technologies.de

Language: English - Date: 2014-11-10 10:14:12
99Pharmacology / Orphan drugs / Monoclonal antibody therapy / Bevacizumab / Trastuzumab / Monoclonal antibodies / B-cell chronic lymphocytic leukemia / Medicine / Immunology / Immune system

Award ID: CC121004 Project Title: Biobetter Cancer Monoclonal Antibody Program Award Mechanism: Company Commercialization

Add to Reading List

Source URL: www.cprit.state.tx.us

Language: English - Date: 2015-03-24 12:30:05
100Anatomy / Immune system / Immunology / Antigen / T helper cell / Immunotherapy / Oncolytic virus / Tumor antigen / Cell-mediated immunity / Medicine / T cells / Biology

Repeated intratumoral administration of ONCOS-102 leads to robust cellular and transcriptional immune activation at tumor site in an ovarian cancer patient Vassilev L.1, Hemminki A.2, Joensuu T.3, Jäger E.4, Karbach J.4

Add to Reading List

Source URL: oncos.com

Language: English - Date: 2014-07-10 04:16:00
UPDATE